0HVB Stock Chart & Stats
$61.70
-$1.56(-2.47%)
At close: 4:00 PM EDT
$61.70
-$1.56(-2.47%)
Day’s Range― - ―
52-Week Range$30.91 - $70.50
Previous CloseN/A
Volume1.11K
Average Volume (3M)4.19K
Market Cap
$34.29B
Enterprise Value$48.14K
Total Cash (Recent Filing)$27.06B
Total Debt (Recent Filing)$16.11B
Price to Earnings (P/E)―
Beta0.22
Next Earnings
Oct 27, 2026EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend Yield0.33%
Share Statistics
EPS (TTM)-10.40
Shares Outstanding493,995,000
10 Day Avg. Volume3,291
30 Day Avg. Volume4,194
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.01
Price to Sales (P/S)0.10
P/FCF Ratio4.68
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$72.64Price Target Upside17.74% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
EPS Forecast (FY)4.8
Revenue Forecast (FY)$195.92B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationStrong operating cash flow and free cash flow give Centene capacity to fund claims, operations, debt reduction, and investment without depending solely on reported earnings. The sharp current FCF improvement is supportive, although historical volatility means conversion must remain consistent.
Improving Operating MarginsLower HBR, improved SG&A, better Medicaid rate assumptions, and upgraded Marketplace and PDP margins indicate active medical-cost and expense control. If sustained, these operating gains can rebuild earnings power across major segments rather than relying on enrollment growth alone.
Large, Diversified PlatformCentene reported $44.4 billion of quarterly premium and service revenue across Medicaid, Marketplace and PDP, demonstrating substantial operating scale. This diversified government-program platform can support care-management capabilities and spread administrative infrastructure across multiple lines.
Bears Say
Recent Profitability DeteriorationTTM revenue declined about 2.2% and operating profit and net income turned negative after positive profitability in 2022–2024. Continued losses would weaken shareholder returns and reduce the flexibility to reinvest, even though the deterioration is described as recent.
Medicaid Membership AttritionManagement now expects Medicaid membership to fall 8%–9% from year-end 2025, worse than its prior 6% decline view. Fewer members can pressure premium scale and fixed-cost absorption, while attrition-related acuity changes may make medical-cost management harder.
Persistent Medical-cost PressuresBehavioral health, home health and high-cost drugs remain important medical-cost pressures, with specialty-drug trends elevated and Medicare Advantage costs above historical averages. Persistent claims inflation could offset rate increases and delay a durable recovery in underwriting margins.
Centene News
0HVB FAQ
What was Centene’s price range in the past 12 months?
Centene lowest share price was $30.91 and its highest was $70.50 in the past 12 months.
What is Centene’s market cap?
Centene’s market cap is $34.29B.
When is Centene’s upcoming earnings report date?
Centene’s upcoming earnings report date is Oct 27, 2026 which is in 40 days.
How were Centene’s earnings last quarter?
Centene released its earnings results on Jul 28, 2026. The company reported $2.51 earnings per share for the quarter, beating the consensus estimate of $1.085 by $1.425.
Is Centene overvalued?
According to Wall Street analysts Centene’s price is currently Undervalued.
Does Centene pay dividends?
Centene pays a Notavailable dividend of $0.285 which represents an annual dividend yield of 0.33%. See more information on Centene dividends here
What is Centene’s EPS estimate?
Centene’s EPS estimate is 0.1.
How many shares outstanding does Centene have?
Centene has 493,995,000 shares outstanding.
What happened to Centene’s price movement after its last earnings report?
Centene reported an EPS of $2.51 in its last earnings report, beating expectations of $1.085. Following the earnings report the stock price went down -1.709%.
Which hedge fund is a major shareholder of Centene?
Currently, no hedge funds are holding shares in GB:0HVB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Centene Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$72.64 (17.74% Upside)
$72.64 (17.74% Upside)
Blogger Sentiment
Bullish
GB:0HVB Sentiment 88%
Sector Average 62%
Sector Average 62%
Insider Transactions
Sold Shares
Worth $6.9M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
107.29%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-3.92%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Centene
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
0HVB Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed solid financial momentum and tangible operational progress: a Q2 EPS beat, raised full-year EPS guidance, margin improvements in Marketplace and PDP, better-than-expected state rate development for Medicaid, strong cash flow and balance-sheet improvements, and measurable cost-management wins (including AI-enabled initiatives). However, the company faces meaningful near-term headwinds: membership attrition (especially in Medicaid expansion), acuity shifts that could pressure medical cost ratios, regulatory/program uncertainty (OB3, STARS, eligibility verification), and a portion of Q2 upside tied to nonrecurring prior-period settlements. On balance, the positive guidance revisions, margin recoveries in key segments, cash and debt improvement, and demonstrated operating discipline outweigh the near-term risks flagged by management.View all GB:0HVB earnings summaries0HVB Revenue Breakdown
88.08% Premium
1.55% Service
10.37% Premium tax
0HVB Stock 12 Month Forecast
Average Price Target
$72.64
▲(17.74% Upside)